Vibalogics
Recipharm is a global Contract Development and Manufacturing Organization (CDMO) dedicated to meeting the evolving needs of pharmaceutical companies through operational excellence, scientific expertise, and customer connectivity. With a history spanning over 25 years, Recipharm offers a wide range of development, manufacturing, and analytical services across multiple locations worldwide, including Europe, India, Israel, North America, Zwickau, and Brescia. The company emphasizes sustainability, quality, and innovation, supporting clients from early development to commercial manufacturing.
Industries
Nr. of Employees
large (251-1000)
Services
Development support for ATMPs and other biologics including process development, analytical development and characterization for clinical and commercial projects.
cGMP clinical and commercial manufacturing across plasmid DNA, mRNA, viral vectors, recombinant proteins and live biotherapeutic products with modular suite configuration.
Aseptic filling and lyophilisation services for vials, pre-filled syringes/cartridges, ampoules and blow-fill-seal single-dose units with pilot and commercial scale options.
Development and manufacturing solutions for oral solids, semi-solids and oral liquids including formulation, scale-up and packaging.
NCE and API development services from route scouting and optimisation to purification, upscaling and GMP manufacture for small molecules.
Analytical method development, validation, QC testing, stability studies and impurity investigations to support release and regulatory dossiers.
Development support for ATMPs and other biologics including process development, analytical development and characterization for clinical and commercial projects.
cGMP clinical and commercial manufacturing across plasmid DNA, mRNA, viral vectors, recombinant proteins and live biotherapeutic products with modular suite configuration.
Aseptic filling and lyophilisation services for vials, pre-filled syringes/cartridges, ampoules and blow-fill-seal single-dose units with pilot and commercial scale options.
Development and manufacturing solutions for oral solids, semi-solids and oral liquids including formulation, scale-up and packaging.
NCE and API development services from route scouting and optimisation to purification, upscaling and GMP manufacture for small molecules.
Analytical method development, validation, QC testing, stability studies and impurity investigations to support release and regulatory dossiers.
Expertise Areas
- Biologics and ATMP development and GMP manufacturing
- Nucleic acid (mRNA, plasmid) drug-substance production
- Viral vector and oncolytic virus manufacturing
- Aseptic fill & finish and sterile product processing
Key Technologies
- Single-use bioprocessing
- Isolator containment systems
- Robotic/automated aseptic filling
- Lyophilisation (freeze-drying)